In recent months The National Institute of Health Care and Excellence (NICE) have released several key guidances on the use of AI in the UK. The recommendations made in these highlight the current position that many companies with AI technologies as a medical device (AIaMD) find themselves in. That is, a need to demonstrate why health systems need them. We take a look at why this is so important.

After investing significant amounts of time, capital, and resources into your healthcare innovation, the crucial next phase is to secure its market success. In this article, we take a look at the building blocks of a strong market strategy.

Wearable devices, such as bracelets, patches, smartwatches, and virtual reality goggles are taking center stage in the digital healthcare revolution. In this article we take a look at how wearables and associated apps are regulated in the EU.

In the medical device industry, the role of intellectual property cannot be overstated. Whether you're a founder of a medical device company or a professional in the field, understanding and protecting your IP is critical for the growth and sustainability of your business.

We hosted our second annual Healthtech Summit, bringing together a diverse community of healthtech leaders to share their stories and learn from each other.

Advertised as a 90 day process, we analysed the data to find out how long it really takes for manufacturers to receive their 510(k) clearance.

If you currently have a UKCA or CE marked medical device on the market you should anticipate unannounced audits to be conducted on your organisation. We explain what they are and how you should be preparing for them.

From ChatGPT to deepfakes, AI development is rapidly progressing. In reaction to the current landscape of AI the European Commission is setting a standard with its new approach to AI regulation through the introduction of the EU Artificial Intelligence Act.

The market launch of your AI product is a huge achievement. It is the point from which you should finally begin to enjoy returns on years of personal and financial investment. We take a look at best practice implementation strategy to ensure success.

We supported AlphaBiomics' co-founder and CEO, Anthony Williamson, to develop a go-to-market (GTM) strategy to help them bring precision medicine to chronic inflammatory diseases.

ISO standards are designed to help businesses ensure that their products and services meet a certain level of quality, safety, and effectiveness. Healthtech has its own standards that organisations may need to conform to, here are the ones that you need to know and where you can find them.

Substantial equivalence of AI systems cannot be reliably proven through technological, safety nor effectiveness characteristics, so is the US 510(k) process robust enough for AI?

Health technology suffered several setbacks the last few months, culminating with Pear Therapeutics recently filing for bankruptcy. Now it’s time to take stock, regroup and work to usher in the next generation of digital therapeutics.

The advent of ChatGPT and similar large language models has created unprecedented excitement for their application in medicine. We explore how it might be possible to use LLMs such as ChatGPT in medical practice under current medical device regulatory frameworks.

When it comes to taking health innovation to the US, digital health companies need to be armed with robust clinical evidence to achieve approval from the Food and Drug Administration (FDA). We share 5 questions that you need to consider from the offset, that will maximise your chances of securing FDA regulatory approval and landing your product on US soil faster.

IEC 62304 is an international standard that defines the lifecycle requirements to develop Software as a Medical Device (SaMD) such that once deployed it is safe, effective, and cybersecure .

Apple and Google’s app stores have new roles in the health and wellness app sector. These companies should comply with new EU medical device regulations and digital EU laws to resolve a cycle of conflicts that currently prevent them from fulfilling their legal obligations.

Learn about the five common mistakes that software as a medical device and AI companies regularly make, which they are perhaps unaware of, or that often go unnoticed until spotted by an external auditor.